Neuroinflammation plays a central role in the pathogenesis of various brain disorders, including neurodegenerative diseases, traumatic brain injury, and psychiatric conditions. In the context of neuroinflammation and brain disorders, this inflammatory response within the central nervous system is often triggered by injury, infection, or chronic disease, leading to the activation of microglia and astrocytes, which contribute to neuronal damage. Research has demonstrated that neuroinflammation accelerates disease progression in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, further driving cognitive decline. Understanding the molecular mechanisms behind neuroinflammation is crucial for developing effective therapeutic strategies. Targeting inflammatory pathways with specific drugs, such as cytokine inhibitors or immune-modulatory agents, holds promise in treating these disorders, aiming to reduce neuronal damage and preserve brain function.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Futurey on neurology
Luiz Moutinho, University of Suffolk, United Kingdom
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Predictors of neurological recovery following traumatic spinal cord
W S El Masri, Keele University, United Kingdom
Title : The vision neurology as bio-recursion and brain-blockchain
Dobilas Kirvelis, Lithuanian Scientific Society, Lithuania